Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment - PubMed (original) (raw)
Review
. 2015 Nov-Dec;44(6):479-86.
doi: 10.1067/j.cpradiol.2015.04.004. Epub 2015 Apr 16.
Affiliations
- PMID: 25979220
- DOI: 10.1067/j.cpradiol.2015.04.004
Review
Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment
Toshimasa Clark et al. Curr Probl Diagn Radiol. 2015 Nov-Dec.
Abstract
Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis, treatment, and surveillance demand a multidisciplinary approach. Knowledge of the underlying pathophysiology as well as advances in clinical management should be employed by radiologists to effectively communicate with hepatologists, surgeons, and oncologists. In this review article, we present recent developments in the clinical management of hepatocellular carcinoma.
Copyright © 2015 Mosby, Inc. All rights reserved.
Similar articles
- Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
Hussain K, El-Serag HB. Hussain K, et al. Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38. Minerva Gastroenterol Dietol. 2009. PMID: 19305372 Review. - Diagnostic and therapeutic management of hepatocellular carcinoma.
Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G. Bellissimo F, et al. World J Gastroenterol. 2015 Nov 14;21(42):12003-21. doi: 10.3748/wjg.v21.i42.12003. World J Gastroenterol. 2015. PMID: 26576088 Free PMC article. Review. - Hepatocellular carcinoma: diagnosis, management, and prognosis.
Page AJ, Cosgrove DC, Philosophe B, Pawlik TM. Page AJ, et al. Surg Oncol Clin N Am. 2014 Apr;23(2):289-311. doi: 10.1016/j.soc.2013.10.006. Epub 2013 Dec 7. Surg Oncol Clin N Am. 2014. PMID: 24560111 Review. - [Diagnostic imaging and therapy of hepatocellular carcinoma].
Allgaier HP, Deibert P, Blum HE. Allgaier HP, et al. Dtsch Med Wochenschr. 1997 Dec 12;122(50):1573-5. Dtsch Med Wochenschr. 1997. PMID: 9445781 German. No abstract available. - Hepatocellular cancer.
Whittle DO, Roberts L. Whittle DO, et al. West Indian Med J. 2009 Jun;58(3):273-6. West Indian Med J. 2009. PMID: 20043538 No abstract available.
Cited by
- Unveiling disulfidptosis-related genes in HBV-associated hepatocellular carcinoma: an integrated study incorporating transcriptome and Mendelian randomization analyses.
Wang X, Xiao K, Liu Z, Wang L, Dong Z, Wang H, Wang Y. Wang X, et al. J Cancer. 2024 Aug 26;15(17):5540-5556. doi: 10.7150/jca.93194. eCollection 2024. J Cancer. 2024. PMID: 39308675 Free PMC article. - Role of APE1 in hepatocellular carcinoma and its prospects as a target in clinical settings (Review).
Yang L, Sun Z. Yang L, et al. Mol Clin Oncol. 2024 Sep 6;21(5):82. doi: 10.3892/mco.2024.2780. eCollection 2024 Nov. Mol Clin Oncol. 2024. PMID: 39301126 Free PMC article. Review. - CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p/NUPR1/FTH1 axis.
Zhang XY, Li SS, Gu YR, Xiao LX, Ma XY, Chen XR, Wang JL, Liao CH, Lin BL, Huang YH, Lian YF. Zhang XY, et al. Mol Cancer. 2024 May 28;23(1):113. doi: 10.1186/s12943-024-02030-x. Mol Cancer. 2024. PMID: 38802795 Free PMC article. - lncRNA SNHG1 promotes the progression of hepatocellular carcinoma by regulating the miR-7-5p/IGF2BP2 axis.
Zhu X, Yu H, Li H, Zhang W, Sun L, Dou T, Wang Z, Zhao H, Yang H. Zhu X, et al. Heliyon. 2024 Mar 9;10(6):e27631. doi: 10.1016/j.heliyon.2024.e27631. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38545199 Free PMC article. - Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
Yuan LX, Luo M, Liu RY, Wang HX, Ju LL, Wang F, Cao YL, Wang ZC, Chen L. Yuan LX, et al. BMC Cancer. 2024 Feb 21;24(1):239. doi: 10.1186/s12885-024-11984-6. BMC Cancer. 2024. PMID: 38383334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical